Billing Management Services for Infectious Disease Practices

Sequential infusions are administered one after another, with one drug or substance completed before the next begins. Concurrent infusions involve two or more substances administered during overlapping periods, often through the same access site or separate lines depending on clinical circumstances. Billing depends on the documented administration sequence, duration, services performed, and applicable coding guidance, so clinical documentation and claim details must align.

A concurrent infusion means multiple infusions are administered during overlapping time periods rather than being fully completed one after another. The clinical record should clearly identify the substances, administration method, timing, and services provided. For billing purposes, the documented sequence and payer requirements matter; practices should review administration coding, supporting documentation, and applicable payer policies instead of assuming that overlapping therapy automatically creates a separately payable service.

Billing management can include charge entry, coding review, claim scrubbing, submission, rejection clearing, denial follow-up, payment reconciliation, aging A/R work, eligibility checks, prior authorization support, and reporting. For infectious disease practices, the workflow may also address E/M visits, hospital consults, infusion administration, drug claims, OPAT courses, and payer or hospital coverage agreements.

Yes. Infectious disease billing workflows can include infusion administration, drug claims, OPAT courses, specialty drugs, eligibility verification, benefit determination, and prior authorization tracking. Effective support also reviews whether documentation and charge capture reflect the work performed. Because reimbursement rules vary by payer and service, each claim should be evaluated against its documentation, coding, contract terms, and applicable medical or pharmacy benefit.

Revenue leakage may appear as under-leveled visits, uncaptured drug or administration charges, missing authorizations, unpursued balances, coding gaps, contract discrepancies, or recurring denials. Reporting by payer, service line, and provider can reveal payment trends and denial patterns. Tracing a gap back to documentation, charge capture, workflow, or contract terms helps the practice address the source rather than only correcting individual claims.

Denial management begins by categorizing denials according to their root causes, such as drug and administration coding, missing authorization, medical versus pharmacy benefit confusion, or insufficient consult documentation. Appeals can then be tailored to payer requirements and supported by clinical records. Reviewing the findings with clinical, coding, and front-office teams helps reduce repeat denials and improve the underlying workflow.

Underpayment review compares actual payment with expected reimbursement for drug, administration, and E/M claims. The analysis may identify short-pays, incorrect fee schedule application, unit mismatches, NDC issues, or contract noncompliance. Findings can be disputed and tracked through recovery. Practices may also use the results during payer or coverage-agreement discussions when reimbursement terms need closer review.

GrowInfectiousDisease offers free, ungated resources and calculators designed to run in the browser without transmitting or storing user-entered data. Practices can apply their own numbers when evaluating revenue streams, operational decisions, and financial sustainability. The resource hub does not publish invented rates, drug acquisition costs, payment rates, or margin figures where verified information is unavailable.